🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Filgrastim - Medicines in Ireland

14 authorised products containing Filgrastim, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 14 authorised medicines
MedicineActive substanceLicence holderStatus
Accofil 30 MU/0.5 ml solution for injection/infusion in pre-filled syringe
EU/1/14/946/001-002
 Filgrastim Accord Healthcare S.L.U. —
Accofil 48 MU/0.5 ml solution for injection/infusion in pre-filled syringe
EU/1/14/943/003-004
 Filgrastim Accord Healthcare S.L.U. —
Neupogen 30 MU (0.3 mg/ml) Solution for injection filgrastim
PA1026/001/001
 Filgrastim Amgen Europe B.V., Marketed
Neupogen Singleject 30 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
PA1026/001/007
 Filgrastim Amgen Europe B.V., Marketed
Neupogen Singleject 48 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
PA1026/001/008
 Filgrastim Amgen Europe B.V., Marketed
Nivestim 12 MU/0.2 ml solution for injection/infusion
EU/1/10/631/001-3
 Filgrastim Pfizer Europe MA EEIG —
Nivestim 30 MU/0.2 ml solution for injection/infusion
EU/1/10/631/004-6
 Filgrastim Pfizer Europe MA EEIG —
Nivestim 48 MU/0.2 ml solution for injection/infusion
EU/1/10/631/007-9
 Filgrastim Pfizer Europe MA EEIG —
Ratiograstim 30 MIU/0.5 ml solution for injection
EU/1/08/444/1-4
 Filgrastim Ratiopharm GmbH —
Ratiograstim 48 MIU/0.8 ml solution for injection
EU/1/08/444/5-8
 Filgrastim Ratiopharm GmbH —
Tevagrastim 30 MIU/0.5 mL solution for injection/infusion
EU/1/08/445/1-4
 Filgrastim Teva Generics GmbH —
Tevagrastim 48 MIU/0.8 mL solution for injection/infusion
EU/1/08/445/5-8
 Filgrastim Teva Generics GmbH —
Zefylti 30 MU/0.5 mL solution for injection/infusion in pre-filled syringe
EU/1/24/1899/001-004
 Filgrastim Curateq Biologics s.r.o. —
Zefylti 48 MU/0.5 mL solution for injection/infusion in pre-filled syringe
EU/1/24/1899/005-008
 Filgrastim Curateq Biologics s.r.o. —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.